550 related articles for article (PubMed ID: 24607885)
1. Complement C5a is detrimental to histological and functional locomotor recovery after spinal cord injury in mice.
Li L; Xiong ZY; Qian ZM; Zhao TZ; Feng H; Hu S; Hu R; Ke Y; Lin J
Neurobiol Dis; 2014 Jun; 66():74-82. PubMed ID: 24607885
[TBL] [Abstract][Full Text] [Related]
2. The Complement Receptor C5aR Controls Acute Inflammation and Astrogliosis following Spinal Cord Injury.
Brennan FH; Gordon R; Lao HW; Biggins PJ; Taylor SM; Franklin RJ; Woodruff TM; Ruitenberg MJ
J Neurosci; 2015 Apr; 35(16):6517-31. PubMed ID: 25904802
[TBL] [Abstract][Full Text] [Related]
3. C5a/C5aR pathway is essential for up-regulating SphK1 expression through p38-MAPK activation in acute liver failure.
Lei YC; Lu CL; Chen L; Ge K; Yang LL; Li W; Wu YH
World J Gastroenterol; 2016 Dec; 22(46):10148-10157. PubMed ID: 28028363
[TBL] [Abstract][Full Text] [Related]
4. Blockade of IL-6 signaling by MR16-1 inhibits reduction of docosahexaenoic acid-containing phosphatidylcholine levels in a mouse model of spinal cord injury.
Arima H; Hanada M; Hayasaka T; Masaki N; Omura T; Xu D; Hasegawa T; Togawa D; Yamato Y; Kobayashi S; Yasuda T; Matsuyama Y; Setou M
Neuroscience; 2014 Jun; 269():1-10. PubMed ID: 24657456
[TBL] [Abstract][Full Text] [Related]
5. Targeting complement anaphylatoxin C5a receptor in hyperoxic lung injury in mice.
Xu Y; Tian Z; Xie P
Mol Med Rep; 2014 Oct; 10(4):1786-92. PubMed ID: 25050483
[TBL] [Abstract][Full Text] [Related]
6. Effects of C5a and Receptor CD88 on Glutamate and N-Methyl-D-Aspartic Acid Receptor Expression in the Mouse Model of Optic Neuromyelitis.
Li L; Tang J; Wang H; Liu J; Zhou L
Comput Math Methods Med; 2022; 2022():4997393. PubMed ID: 35509858
[TBL] [Abstract][Full Text] [Related]
7. Administration of C5a Receptor Antagonist Improves the Efficacy of Human Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cell Transplantation in the Acute Phase of Spinal Cord Injury.
Shibata R; Nagoshi N; Kajikawa K; Ito S; Shibata S; Shindo T; Khazaei M; Nori S; Kohyama J; Fehlings MG; Matsumoto M; Nakamura M; Okano H
J Neurotrauma; 2022 May; 39(9-10):667-682. PubMed ID: 35196890
[TBL] [Abstract][Full Text] [Related]
8. [The roles of C5a and C5aR antagonist in TNF-α secretion and CD88 expression of BV2 microglial cells treated with Aβ1-42 oligomer].
Yang F; Li D; Xu S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Mar; 29(3):265-8. PubMed ID: 23643083
[TBL] [Abstract][Full Text] [Related]
9. C5a receptor targeting in neointima formation after arterial injury in atherosclerosis-prone mice.
Shagdarsuren E; Bidzhekov K; Mause SF; Simsekyilmaz S; Polakowski T; Hawlisch H; Gessner JE; Zernecke A; Weber C
Circulation; 2010 Sep; 122(10):1026-36. PubMed ID: 20733098
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of thymosin β4 on spinal cord injury in the rat.
Cheng P; Kuang F; Zhang H; Ju G; Wang J
Neuropharmacology; 2014 Oct; 85():408-16. PubMed ID: 24937047
[TBL] [Abstract][Full Text] [Related]
11. Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats.
Bethea JR; Nagashima H; Acosta MC; Briceno C; Gomez F; Marcillo AE; Loor K; Green J; Dietrich WD
J Neurotrauma; 1999 Oct; 16(10):851-63. PubMed ID: 10547095
[TBL] [Abstract][Full Text] [Related]
12. C5aR inhibition in the early inflammatory phase does not affect bone regeneration in a model of uneventful fracture healing.
Ehrnthaller C; Huber-Lang M; Kovtun A; Rapp AE; Kemmler J; Gebhard F; Ignatius A
Eur J Med Res; 2016 Oct; 21(1):42. PubMed ID: 27784330
[TBL] [Abstract][Full Text] [Related]
13. C5a/C5aR pathway is essential for the pathogenesis of murine viral fulminant hepatitis by way of potentiating Fgl2/fibroleukin expression.
Xu GL; Chen J; Yang F; Li GQ; Zheng LX; Wu YZ
Hepatology; 2014 Jul; 60(1):114-24. PubMed ID: 24604562
[TBL] [Abstract][Full Text] [Related]
14. Expressions of C5a and its receptor CD88 after spinal cord injury in C3-deficient mice.
Guo Q; Cheng J; Zhang H; Zhang J; Su B; Bian C; Lin S
Scand J Immunol; 2013 Apr; 77(4):224-9. PubMed ID: 23033813
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of acute inflammatory response by atorvastatin after spinal cord injury in rats.
Pannu R; Barbosa E; Singh AK; Singh I
J Neurosci Res; 2005 Feb; 79(3):340-50. PubMed ID: 15605375
[TBL] [Abstract][Full Text] [Related]
16. The immunomodulator decoy receptor 3 improves locomotor functional recovery after spinal cord injury.
Chiu CW; Huang WH; Lin SJ; Tsai MJ; Ma H; Hsieh SL; Cheng H
J Neuroinflammation; 2016 Jun; 13(1):154. PubMed ID: 27316538
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of p21-Activated Kinase 1 by IPA-3 Promotes Locomotor Recovery After Spinal Cord Injury in Mice.
Ji X; Zhang Y; Zhang L; Chen H; Peng Y; Tang P
Spine (Phila Pa 1976); 2016 Jun; 41(11):919-925. PubMed ID: 26863260
[TBL] [Abstract][Full Text] [Related]
18. Age decreases macrophage IL-10 expression: Implications for functional recovery and tissue repair in spinal cord injury.
Zhang B; Bailey WM; Braun KJ; Gensel JC
Exp Neurol; 2015 Nov; 273():83-91. PubMed ID: 26263843
[TBL] [Abstract][Full Text] [Related]
19. Delayed granulocyte colony-stimulating factor treatment promotes functional recovery in rats with severe contusive spinal cord injury.
Lee JS; Yang CC; Kuo YM; Sze CI; Hsu JY; Huang YH; Tzeng SF; Tsai CL; Chen HH; Jou IM
Spine (Phila Pa 1976); 2012 Jan; 37(1):10-7. PubMed ID: 22024901
[TBL] [Abstract][Full Text] [Related]
20. Effect of ZBD-2 on chronic pain, depressive-like behaviors, and recovery of motor function following spinal cord injury in mice.
Li XM; Meng J; Li LT; Guo T; Yang LK; Shi QX; Li XB; Chen Y; Yang Q; Zhao JN
Behav Brain Res; 2017 Mar; 322(Pt A):92-99. PubMed ID: 28108322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
